Dec 27, 2017

Cartiva to Present at 36th Annual J.P. Morgan Healthcare Conference

Alpharetta, GA, December 27, 2017 – Cartiva, Inc., a medical device company focused on the treatment of osteoarthritis of the extremities, today announced that Tim Patrick, President and Chief Executive Officer, will present at the 36th Annual J.P. Morgan Healthcare Conference in San Francisco. Mr. Patrick is scheduled to present at 8:30 a.m. PST on Wednesday, January 10, 2018.

About Cartiva, Inc.

Based in Alpharetta, Ga., Cartiva, Inc. is a medical device company focused on the treatment of osteoarthritis of the extremities. Cartiva’s synthetic cartilage is the only FDA-approved biomedical implant that mimics natural cartilage. The company’s venture investors include New Enterprise Associates and Windham Venture Partners. Additional information is available on the company’s website at www.cartiva.net.